Recent claims of a breakthrough cure for pancreatic cancer by Spanish scientists have led to overwhelming inquiries from patients, but the implications of such a treatment's effectiveness in humans remain uncertain.
In recent days, reports have emerged of a promising new treatment for pancreatic cancer spearheaded by biochemist Mariano Barbacid at Spain's National Cancer Research Centre (CNIO), prompting over a hundred patients to seek help from him. Barbacid called a press conference on January 27 where he discussed his breakthrough therapy, creating visible excitement in the medical community and among patients, which was only amplified by a social media announcement from his company, Vega Oncotargets, stating it as the 'first effective therapy against pancreatic cancer.' This has led many to believe that pancreatic cancer might soon be treatable.
